相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia
Wing Leung et al.
BLOOD (2012)
High-Risk Pediatric Acute Lymphoblastic Leukemia: To Transplant or Not to Transplant?
Michael A. Pulsipher et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer
Hernan Carol et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Introduction of a Quality Management System and Outcome After Hematopoietic Stem-Cell Transplantation
Alois Gratwohl et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
Ching-Hon Pui et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Improving Outcomes for High-Risk ALL: Translating New Discoveries Into Clinical Care
Stephen P. Hunger et al.
PEDIATRIC BLOOD & CANCER (2011)
Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors
Peter J. Shaw et al.
BLOOD (2010)
Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study
Richard H. Ko et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90
Gesche Tallen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial
Catriona Parker et al.
LANCET (2010)
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation.
Ted A. Gooley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Allogeneic Transplantation for Pediatric Acute Lymphoblastic Leukemia: The Emerging Role of Peritransplantation Minimal Residual Disease/Chimerism Monitoring and Novel Chemotherapeutic, Molecular, and Immune Approaches Aimed at Preventing Relapse
Michael A. Pulsipher et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Donor and Recipient CMV Serostatus and Outcome of Pediatric Allogeneic HSCT for Acute Leukemia in the Era of CMV-Preemptive Therapy
Carolyn E. Behrendt et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Pediatric related and unrelated cord blood transplantation for malignant diseases
V. Rocha et al.
BONE MARROW TRANSPLANTATION (2009)
Risk Score for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation A Retrospective Analysis
Alois Gratwohl et al.
CANCER (2009)
Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group
Peter Bader et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
Kirk R. Schultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants
Naynesh Kamani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program
Margaret L. MacMillan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies
Joanne Kurtzberg et al.
BLOOD (2008)
Strategies of the donor search for children with second CR ALL lacking a matched sibling donor
E. Lanino et al.
BONE MARROW TRANSPLANTATION (2008)
Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children
Amrana Qureshi et al.
PEDIATRIC BLOOD & CANCER (2008)
Searching for alternative hematopoietic stem cell donors for pediatric patients
V. Rocha et al.
BONE MARROW TRANSPLANTATION (2008)
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
Stephanie J. Lee et al.
BLOOD (2007)
Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation
D. K. L. Cheuk et al.
BONE MARROW TRANSPLANTATION (2007)
Single nucleotide Polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors
Neema P. Mayor et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study
Mary Eapen et al.
LANCET (2007)
Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation
M. Miano et al.
BONE MARROW TRANSPLANTATION (2007)
Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months
M Eapen et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH)
MA Diaz et al.
BONE MARROW TRANSPLANTATION (2005)
Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM/IBFM/EBMT concepts
C Peters et al.
BONE MARROW TRANSPLANTATION (2005)
The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy
M Boeckh et al.
BLOOD (2004)
National marrow donor program HLA-matching guidelines for unrelated marrow transplants
CK Hurley et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis
A Borgmann et al.
BLOOD (2003)
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors
F Locatelli et al.
LEUKEMIA (2002)
Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL
P Bader et al.
LEUKEMIA (2002)
Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission
N Bunin et al.
BLOOD (2002)
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children
AE Woolfrey et al.
BLOOD (2002)
No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission
UM Saarinen-Pihkala et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Minimal residual disease in leukaemia patients
Tomasz Szczepanski et al.
LANCET ONCOLOGY (2001)
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia
V Rocha et al.
BLOOD (2001)
分享论文
